Claudio N. Soares

Claudio N. Soares

Auto-generated profile, based on publicly available information

Claudio N. Soares

Queen's University School of Medicine

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Medical Clinics of North America
Verified
Journal Article
Closed access
CSClaudio N. Soares
Claudio N. Soares

1 June 2017 in Psychiatric Clinics of North America
Verified
Journal Article
Closed access
CSClaudio N. Soares
Claudio N. Soares

1 September 2019 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Closed access
EBElisa Brietzke
Elisa Brietzke
EHEmily R. Hawken
Emily R. Hawken
MIMaia Idzikowski
Maia Idzikowski
JPJanice Pong
Janice Pong
SKSidney H. Kennedy
Sidney H. Kennedy
CSClaudio N. Soares
Claudio N. Soares

1 March 2021 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
MRMichael J. Raphael
Michael J. Raphael
SGSumit Gupta
Sumit Gupta
XWXuejiao Wei
Xuejiao Wei
YPYingwei Peng
Yingwei Peng
CSClaudio N. Soares
Claudio N. Soares
CBChristopher Booth
Christopher Booth
PURPOSE: Testicular cancer survivors may experience mental illness as a consequence of their cancer diagnosis and treatment. METHODS: All incident cases of testicular cancer treated with orchiectomy in Ontario, Canada (2000-2010), were identified using the Ontario Cancer Registry. Cases were matched to controls in a 1:5 ratio on age and geography. Population-level databases were used to identify mental health service use episodes; outpatient use included visits to a general practitioner for a mental health concern or any visit to a psychiatrist. Negative binomial regression modeling was used to estimate the rate of mental health service use in the pretreatment (2 years prior until 1 month before orchiectomy), peritreatment (1 month before until 1 month after orchiectomy), and post-treatment periods (1 month after orchiectomy until end of follow-up). Rate ratios (RR) comparing cases with controls in the peri- and post-treatment periods were adjusted for baseline mental health service use. RESULTS: Two thousand six hundred nineteen cases of testicular cancer were matched to 13,095 controls. There was no baseline difference in the rate of mental health service use. Cases were significantly more likely than controls to have an outpatient visit for a mental health concern in the peritreatment (adjusted RR [aRR], 2.45; 95% CI, 2.06 to 2.92) and post-treatment periods (aRR, 1.30; 95% CI, 1.12 to 1.52). The difference in mental health service use persisted over a median follow-up of 12 years. In the postorchiectomy period, cases with baseline mental health service use were those most likely to use mental health services (aRR, 5.64; 95% CI, 4.64 to 6.85). CONCLUSION: Testicular cancer survivors use mental health services more often than healthy controls. Survivorship care plans that address the long-term mental healthcare needs of this population are needed.

1 December 2020 in JMIR Research Protocols
Verified
Journal Article
Open access
NANazanin Alavi
Nazanin Alavi
MYMegan Yang
Megan Yang
CSCallum Stephenson
Callum Stephenson
NNNiloofar Nikjoo
Niloofar Nikjoo
NMNiloufar Malakouti
Niloufar Malakouti
CSClaudio N Soares
Claudio N Soares
Background: The considerable rise of mental health challenges during the COVID-19 pandemic has had detrimental effects on the public health sector and economy. To meet the overwhelming and growing demand for mental health care, innovative approaches must be employed to significantly expand mental health care delivery capacity. Although it is not feasible to increase the number of mental health care providers or hours they work in the short term, improving their time efficiency may be a viable solution. Virtually and digitally delivering psychotherapy, which has been shown to be efficient and clinically effective, might be a good method for addressing this growing demand. Objective: This research protocol aims to evaluate the feasibility and efficacy of using an online, digital, asynchronous care model to treat mental health issues that are started or aggravated by stressors associated with the COVID-19 pandemic. Methods: This nonrandomized controlled trial intervention will be delivered through the Online Psychotherapy Tool, a secure, cloud-based, digital mental health platform. Participants will be offered a 9-week electronically delivered cognitive behavioral therapy program that is tailored to address mental health problems in the context of the COVID-19 pandemic. This program will involve weekly self-guided educational material that provides an overview of behavioral skills and weekly homework. Participants (N=80) will receive personalized feedback from and weekly interaction with a therapist throughout the course of the program. The efficacy of the program will be evaluated using clinically validated symptomology questionnaires, which are to be completed by participants at baseline, week 5, and posttreatment. Inclusion criteria includes the capacity to consent; a primary diagnosis of generalized anxiety disorder or major depressive disorder, with symptoms that started or worsened during the COVID-19 pandemic; the ability to speak and read English; and consistent and reliable access to the internet. Exclusion criteria includes active psychosis, acute mania, severe alcohol or substance use disorder, and active suicidal or homicidal ideation. Results: This study received funding in May 2020. Ethics approval was received in June 2020. The recruitment of participants began in June 2020. Participant recruitment is being conducted via social media, web-based communities, and physician referrals. To date, 58 participants have been recruited (intervention group: n=35; control group: n=23). Data collection is expected to conclude by the end of 2020. Analyses (ie, linear regression analysis for continuous outcomes and binomial regression analysis for categorical outcomes) are expected to be completed by February 2021. Conclusions: If proven feasible, this care delivery method could increase care capacity by up to fourfold. The findings from this study can potentially influence clinical practices and policies and increase accessibility to care during the COVID-19 pandemic, without sacrificing the quality of care.

1 February 2014 in Appetite
Verified
Journal Article
Closed access
PSPatrícia Pelufo Silveira
Patrícia Pelufo Silveira
APAndré Krumel Portella
André Krumel Portella
JKJames L. Kennedy
James L. Kennedy
HGHélène Gaudreau
Hélène Gaudreau
CDCaroline Davis
Caroline Davis
RLRobert D. Levitan
Robert D. Levitan